79 related articles for article (PubMed ID: 21778310)
1. CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience.
Collettini F; Poellinger A; Schnapauff D; Denecke T; Wust P; Braicu IE; Sehouli J; Hamm B; Gebauer B
Anticancer Res; 2011 Aug; 31(8):2597-602. PubMed ID: 21778310
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT).
Geisel D; Denecke T; Collettini F; Grieser C; Wust P; Thuss-Patience P; Hamm B; Gebauer B
Anticancer Res; 2012 Dec; 32(12):5453-8. PubMed ID: 23225451
[TBL] [Abstract][Full Text] [Related]
3. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
4. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
5. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
[TBL] [Abstract][Full Text] [Related]
6. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
[TBL] [Abstract][Full Text] [Related]
10. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
11. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
13. Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series.
Geisel D; Collettini F; Denecke T; Grieser C; Flörcken A; Wust P; Hamm B; Gebauer B
World J Urol; 2013 Dec; 31(6):1525-30. PubMed ID: 23132612
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-guided brachytherapy for liver cancer.
Ricke J; Wust P
Semin Radiat Oncol; 2011 Oct; 21(4):287-93. PubMed ID: 21939858
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
Tan LT; Coles CE; Hart C; Tait E
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
[TBL] [Abstract][Full Text] [Related]
17. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
18. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation.
Ricke J; Seidensticker M; Lüdemann L; Pech M; Wieners G; Hengst S; Mohnike K; Cho CH; Lopez Hänninen E; Al-Abadi H; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):776-84. PubMed ID: 15936559
[TBL] [Abstract][Full Text] [Related]
19. CT-guided multi-catheter insertion technique for partial breast brachytherapy: reliable target coverage and dose homogeneity.
Cuttino LW; Todor D; Arthur DW
Brachytherapy; 2005; 4(1):10-7. PubMed ID: 15737901
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
Tselis N; Ratka M; Vogt HG; Kolotas C; Baghi M; Baltas D; Fountzilas G; Georgoulias V; Ackermann H; Zamboglou N
Radiother Oncol; 2011 Jan; 98(1):57-62. PubMed ID: 21129799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
